Learn More
Carboxypeptidase B2 Monoclonal Antibody (5024), Invitrogen™
Mouse Monoclonal Antibody
Marke: Invitrogen MA143023
Weitere Details : Netto-Gewicht : 0.01000kg
Beschreibung
MA1-43023 detects TAFI in human samples. MA1-43023 has successfully been used in Western Blot, ELISA, and Inhibition Assay applications. MA1-43023 was derived from human TAFI and activated TAFI.
Carboxypeptidases are enzymes that hydrolyze C-terminal peptide bonds. The carboxypeptidase family includes metallo-, serine, and cysteine carboxypeptidases. According to their substrate specificity, these enzymes are referred to as carboxypeptidase A (cleaving aliphatic residues) or carboxypeptidase B (cleaving basic amino residues). CPB2 is activated by trypsin and acts on carboxypeptidase B substrates. After thrombin activation, the mature protein downregulates fibrinolysis. Polymorphisms have been described for its gene and its promoter region.Spezifikation
Carboxypeptidase B2 | |
Monoclonal | |
10 mg/mL | |
50% water with 50% glycerol and no preservative | |
Q96IY4 | |
CPB2 | |
Human TAFI | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG1 |
ELISA, Inhibition Assays, Western Blot | |
5024 | |
Unconjugated | |
CPB2 | |
1110032P04Rik; 4930405E17Rik; AI255929; carboxypeptidase B2; carboxypeptidase B2 (plasma); carboxypeptidase B2 (plasma, carboxypeptidase U); carboxypeptidase B-like protein; carboxypeptidase R; Carboxypeptidase U; Cpb2; CPR; CPU; pCPB; Plasma carboxypeptidase B; Tafi; thrombin-activable fibrinolysis inhibitor; thrombin-activatable fibrinolysis inhibitor | |
Mouse | |
Ammonium sulfate precipitation, Ion-exchange chromatography | |
RUO | |
1361 | |
-20° C, Avoid Freeze/Thaw Cycles | |
Liquid |